ReviewFrontiers in immunology2026
The dual-sensitive period gut-brain crosstalk, neuroinflammation, and the biological roots of adolescent depression.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing burden of adolescent depression underscores the need to identify developmental vulnerabilities and biologically informed strategies for prevention and intervention. This review synthesizes evidence supporting adolescence as a "dual-sensitive period" during which concurrent maturation of the brain and gut microbiota may create a window of susceptibility to perturbations of the microbiota-gut-brain axis (MGBA). During this stage, dysregulated gut-brain communication may contribute to low-grade inflammation, impaired barrier function, altered HPA-axis responsivity, and changes in tryptophan-, short-chain fatty acid-, and neurotransmitter-related metabolism. In particular, inflammatory signaling and microglial activation may link gut dysbiosis to maladaptive synaptic remodeling, although direct causal evidence in adolescents remains limited. The review also examines the "microgenderome" framework as a lens for understanding potential sex-related differences in depression, and considers environmental exposures such as diet, antibiotics, and sleep disruption as perturbing influences on MGBA homeostasis. Translationally, psychobiotics, dietary optimization, and related microbiota-informed approaches may hold promise as adjunctive or preventive strategies, but they are not yet established standalone treatments for adolescent depression. Future studies integrating longitudinal design, multi-omics profiling, biomarkers, and adolescent-specific intervention trials will be essential to clarify causality and guide precision prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.